Nick Dessypris

Dr. Nick Dessypris


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2013 in Cancer Epidemiology
Verified
Journal Article
Closed access
CMCatherine Metayer
Catherine Metayer
EMElizabeth Milne
Elizabeth Milne
JCJacqueline Clavel
Jacqueline Clavel
CIClaire Infante-Rivard
Claire Infante-Rivard
EPEleni Petridou
Eleni Petridou
PBPatricia A. Buffler
Patricia A. Buffler

19 September 2019 in Sustainability
Verified
Journal Article
Open access
PDF file
GPGeorgios Panagakos
Georgios Panagakos
TPThiago de Sousa Pessôa
Thiago de Sousa Pessôa
NDNick Dessypris
Nick Dessypris
MBMichael Bruhn Barfod
Michael Bruhn Barfod
HPHarilaos N. Psaraftis
Harilaos N. Psaraftis
Aiming at reducing CO2 emissions from shipping at the EU level, a system for monitoring, reporting, and verification (MRV) of CO2 emissions of ships was introduced in 2015 with the so-called ‘MRV Regulation’. Its stated objective was to produce accurate information on the CO2 emissions of large ships using EU ports and to incentivize energy efficiency improvements by making this information publicly available. On 1 July 2019, the European Commission published the relevant data for 10,880 ships that called at EU ports within 2018. This milestone marked the completion of the first annual cycle of the regulation’s implementation, enabling an early assessment of its effectiveness. To investigate the value of the published data, information was collected on all voyages performed within 2018 by a fleet of 1041 dry bulk carriers operated by a leading Danish shipping company. The MRV indicators were then recalculated on a global basis. The results indicate that the geographic coverage restrictions of the MRV Regulation introduce a significant bias, thus prohibiting their intended use. Nevertheless, the MRV Regulation has played a role in prompting the IMO to adopt its Data Collection System that monitors ship carbon emissions albeit on a global basis.

23 October 2024 in Children
Verified
Journal Article
Open access
PDF file
Filippos FilippatosFilippos Filippatos
Filippos Filippatos
MTMarianna Tzanoudaki
Marianna Tzanoudaki
Elizabeth-Barbara TatsiElizabeth-Barbara Tatsi
Elizabeth-Barbara Tatsi
NDNick Dessypris
Nick Dessypris
DKDimitra-Maria Koukou
Dimitra-Maria Koukou
Athanasios MichosAthanasios Michos
Athanasios Michos
Background/objectives: The immunological pathways that cause Multisystem Inflammatory Syndrome after SARS-CoV-2 infection in children (MIS-C) remain under investigation. Methods: The aim of this study was to prospectively compare the T-cell cytokine expression profile in unvaccinated children with acute MIS-C (MISC_A) before immunosuppression, convalescent MIS-C (one month after syndrome onset, MISC_C), convalescent COVID-19 (one month after hospitalization), and in healthy, unvaccinated controls. The intracellular expression of IL-4, IL-2, IL-17, IFNγ, TNF-α and Granzyme B, and the post SARS-CoV-2-Spike antigenic mix stimulation of T-cell subsets was analyzed by 13-color flow cytometry. Results: Twenty children with a median age (IQR) of 11.5 (7.25–14) years were included in the study. From the comparison of the flow cytometry analysis of the 14 markers of MISC_A with the other three groups (MISC_C, post-COVID-19 and controls), significant differences were identified as follows: 1. CD4+IL-17+/million CD3+: 293.0(256.4–870.9) vs. 50.7(8.4–140.5); p-value: 0.03, vs. 96.7(89.2–135.4); p-value: 0.03 and vs. 8.7(0.0–82.4); p-value: 0.03, respectively; 2. CD8+IL-17+/million CD3+: 335.2(225.8–429.9) vs. 78.0(31.9–128.9) vs. 84.1(0.0–204.6) vs. 33.2(0.0–114.6); p-value: 0.05, respectively; 3. CD8+IFNγ+/million CD3+: 162.2(91.6–273.4) vs. 41.5(0.0–77.4); p-value: 0.03 vs. 30.3(0.0–92.8); p-value: 0.08, respectively. Conclusions: In children presenting with MIS-C one month after COVID-19 infection, T cells were found to be polarized towards IL-17 and IFNγ production compared to those with uncomplicated convalescent COVID-19, a finding that could provide possible immunological biomarkers for MIS-C detection.

15 February 2020 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
TSTania Siahanidou
Tania Siahanidou
MKMary Karalexi
Mary Karalexi
MKMARIA KANTZANOU
MARIA KANTZANOU
NDNick Dessypris
Nick Dessypris
CCChristos Christodoulakis
Christos Christodoulakis
EPEleni Th. Petridou
Eleni Th. Petridou

23 September 2024 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
MDMaria-Myrto Maria-Myrto Dourdouna
Maria-Myrto Maria-Myrto Dourdouna
EMEVDOXIA MPOURAZANI
EVDOXIA MPOURAZANI
Elizabeth-Barbara TatsiElizabeth-Barbara Tatsi
Elizabeth-Barbara Tatsi
CTChrysanthi Tsirogianni
Chrysanthi Tsirogianni
CBCharikleia Barbaressou
Charikleia Barbaressou
Athanasios MichosAthanasios Michos
Athanasios Michos
Background/Objectives: Multisystem Inflammatory Syndrome in children (MIS-C) is a rare but severe post-infectious complication of COVID-19 that often requires admission to the Pediatric Intensive Care Unit (PICU). The present study aimed to compare the demographic, clinical, and laboratory characteristics of children diagnosed with MIS-C who were admitted to the PICU and those who did not require PICU admission. Methods: Children diagnosed with MIS-C from September 2020 to April 2023 were included in this case-control study. Demographic, clinical, and laboratory data were collected from medical records. Results: Fifty children with MIS-C were included in the study [median (IQR) age: 7.5 (4.3, 11.4) years, 28/50 (56%) males]. Twenty-two (22/50, 44%) children required admission to the PICU. In the multivariate regression analysis, hepatic (OR: 12.89, 95%CI: 1.35–123.41, p-value = 0.03) and cardiological involvement (OR: 34.55, 95%CI: 2.2–541.91, p-value = 0.01) were significantly associated with hospitalization at the PICU. Regarding the laboratory and imaging parameters during the first 48 h from admission, D-dimer levels higher than 4 μg/mL and decreased Left Ventricular Ejection Fraction (LVEF) were associated with an increased risk of PICU admission (OR: 7.95, 95%CI: 1.48–42.78, p-value = 0.02 and OR = 1.28, 95%CI: 1.07–1.53, p-value = 0.01). Children who were admitted to the PICU were more likely to develop complications during their hospitalization (10/22, 45.5% vs. 3/28, 10.7%, p-value = 0.005) and were hospitalized for more days than children in the pediatric ward (median length of stay (IQR): 20 (15, 28) days vs. 8.5 (6, 14) days, p-value < 0.001). Conclusions: The findings of this study indicate that cardiovascular and hepatic involvement and increased D-dimer levels in children with MIS-C might be associated with admission to the PICU.

30 August 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MDMaria-Myrto Maria-Myrto Dourdouna
Maria-Myrto Maria-Myrto Dourdouna
EMEVDOXIA MPOURAZANI
EVDOXIA MPOURAZANI
Elizabeth-Barbara TatsiElizabeth-Barbara Tatsi
Elizabeth-Barbara Tatsi
CTChrysanthi Tsirogianni
Chrysanthi Tsirogianni
CBCharikleia Barbaressou
Charikleia Barbaressou
Athanasios MichosAthanasios Michos
Athanasios Michos
Background/Objectives: Multisystem Inflammatory Syndrome in children (MIS-C) is a rare but severe post-infectious complication of COVID-19, that often requires admission to the Pediatric Intensive Care Unit (PICU). The present study aimed to compare the demographic, clinical and laboratory characteristics between children diagnosed with MIS-C who were admitted to the PICU or did not require PICU admission. Methods: Children diagnosed with MIS-C from September 2020 to April 2023 were included in this case-control study. Patient’s demographic, clinical and laboratory data, were collected from medical records. Results: Fifty children with MIS-C were included in the study [median (IQR) age: 7.5 (4.3, 11.4) years, 28/50 (56%) males]. Twenty-two (22/50, 44%) children required admission to the PICU. In the multivariate regression analysis, hepatic (OR:12.89, 95%CI: 1.35-123.41, p-value=0.03) and cardiological involvement (OR:34.55, 95%CI: 2.2-541.91, p-value=0.01) were significantly associated with hospitalization at the PICU. Regarding the laboratory and imaging parameters during the first 48 hours from admission, D-dimer levels higher than 4μg/mL and decreased Left Ventricular Ejection Fraction were associated with an increased risk of PICU admission (OR:7.95, 95%CI:1.48-42.78, p-value=0.02 and OR=1.28, 95%CI:1.07-1.53, p-value=0.01). Children who were admitted to the PICU were more likely to develop complications during their hospitalization (10/22, 45.5% vs. 3/28, 10.7%, p-value=0.005) and were hospitalized for more days, than children in the pediatric wards (median length of stay (IQR): 20 (15,28) days vs. 8.5 (6, 14) days, p-value<0.001). Conclusions: In the present study, cardiovascular, hepatic involvement and increased D-dimer levels in children with MIS-C were associated with admission to the PICU.